SCHEMBL14068917

SCHEMBL14068917

CCCC(C(=O)c1ccccc1)C1CCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.52
SLC6A3 Q01959 2/20 0.52
LMNA P02545 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
SCN1A P35498 1/20 0.42
SCN2A Q99250 1/20 0.42
SCN3A Q9NY46 1/20 0.42
ADRA2A P08913 2/20 0.41
KCNH2 Q12809 2/20 0.41
PGR P06401 1/20 0.41
ADRA2B P18089 1/20 0.41
HTR2A P28223 1/20 0.41
HRH1 P35367 1/20 0.41
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27098482 0.81 HTR3E (0.50) SLC6A2SLC6A3ALDH1A1CHRM3CHRM2
SCHEMBL14068922 0.81 LMNA (0.48) LMNACYP1A2CYP2D6SCN1ASCN2A
SCHEMBL9127307 0.81 SLC6A2 (0.44) SLC6A2SLC6A3LMNACYP1A2CYP2D6
SCHEMBL14068930 0.78 LMNA (0.39) SLC6A2SLC6A3LMNACYP1A2CYP2D6
SCHEMBL14068924 0.77 SLC6A2 (0.40) SLC6A2SLC6A3LMNACYP1A2CYP2D6
SCHEMBL14068925 0.77 CYP2C19 (0.41) SLC6A2SLC6A3LMNACYP1A2CYP2D6
SCHEMBL27755191 0.77 ALDH1A1 (0.48) SLC6A2SLC6A3LMNACYP1A2CYP2D6
SCHEMBL14068901 0.76 KMT2A (0.44) SLC6A2SLC6A3LMNACYP1A2CYP2D6
SCHEMBL11134603 0.76 CYP2C19 (0.41) SLC6A2SLC6A3LMNACYP1A2CYP2D6
SCHEMBL4978863 0.76 SMN1; SMN2 (0.46) SLC6A3HTR2AHRH1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234498-A1 Pyrovalerone Analogues and Therapeutic Uses Thereof PRESIDENT AND FELLOW OF HARVARD COLLEGE (US) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234498-A1 Pyrovalerone Analogues and Therapeutic Uses Thereof SLC6A2, SLC6A4, SLC6A3 SLC6A2 1/4885SLC6A3 3/4885LMNA 4124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.